Physician profile
Robert E Beer
NPI 1467492751
$61,537.00
in general payments reported to CMS, 2019-2025
34 companies · $4,784 in 2025
The $4,784 reported for 2025 was more than what 89% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,949 · 2020: $1,126 · 2021: $24K · 2022: $15K · 2023: $9,735 · 2024: $5,775 · 2025: $4,784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Food and Beverage: $3,753 · Education: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,128.85 |
| Food and Beverage | $3,753.37 |
| Education | $412.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $38,286.56 | 2019-2023 | |
| Abbvie INC. | $16,501.02 | 2019-2025 | Skyrizi, Botox, Rinvoq |
| Janssen Biotech, INC. | $947.30 | 2019-2025 | Tremfya, Simponi, Stelara |
| Novartis Pharmaceuticals Corporation | $818.73 | 2019-2024 | |
| Lilly USA, LLC | $766.05 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Pfizer INC. | $748.74 | 2019-2025 | |
| Dermavant Sciences, INC. | $362.61 | 2022-2024 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $272.94 | 2022-2025 | Sotyktu |
| Mayne Pharma Commercial LLC | $272.91 | 2019-2021 | |
| Genentech USA, INC. | $237.38 | 2019-2020 | |
| Incyte Corporation | $230.62 | 2021-2024 | Opzelura |
| Genzyme Corporation | $195.85 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $193.96 | 2019-2024 | Absorica Ld, Winlevi |
| Kyowa Kirin, INC. | $188.98 | 2022-2024 | Poteligeo |
| Regeneron Healthcare Solutions, INC. | $167.08 | 2019-2025 | Dupixent, Libtayo |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sensus Healthcare, INC. | $155.00 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $141.56 | 2020-2024 | Jublia |
| Dermira, INC. | $131.04 | 2020-2021 | |
| Ucb, INC. | $130.75 | 2020-2025 | Bimzelx, Cimzia |
| Pierre Fabre Pharmaceuticals, INC. | $130.64 | 2019 | |
| Amgen INC. | $129.18 | 2019-2024 | Otezla |
| Galderma Laboratories, L.P. | $121.94 | 2019-2025 | Nemluvio |
| Journey Medical Corporation | $67.11 | 2019-2020 | |
| Organon LLC | $60.09 | 2025 | Nexplanon |
| Helsinn Therapeutics (U.S.), INC. | $55.90 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $40.00 | 2019 | |
| Arcutis Biotherapeutics, INC. | $38.19 | 2023 | |
| Dusa Pharmaceuticals, INC. | $29.49 | 2019 | |
| Cipher Pharmaceuticals US LLC | $24.95 | 2025 | Spinosad, Natroba |
| Taro Pharmaceuticals USA, INC. | $21.95 | 2019 | |
| Leo Pharma INC. | $21.43 | 2023 | Adbry |
| Almirall LLC | $15.96 | 2021 | |
| Mission Pharmacal Company | $15.65 | 2019 | |
| Epi Health, LLC | $15.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Beer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.